Destructive innovation can really change the way healthcare is delivered and the way drugs are used, which is fascinating. In the near future, huge technological changes will promote the transformation and upgrading of pharmaceutical companies.
However, if we are not prepared for the upcoming changes, the existing medical system will be destroyed, and the rest will be the underlying technical services that lack interpersonal communication. We should not easily eliminate such a complex system, but should redesign it consciously, purposefully, and in stages. In order to seize this opportunity, we must be prepared for the challenges of the future.
Therefore, it is recommended that pharmaceutical companies take immediate action, otherwise they will suffer losses and even face the dilemma of bankruptcy. What if we use the funds, expertise, and time to treat the disease to prevent disease? This means that we will have a healthier body, and the existing business of a pharmaceutical company will lose its core meaning. Still hesitating about the authenticity of these radical speeches? Let's take a look at the following trends and cases.
Give patients more power
After gaining higher authority, patients will establish an equal partnership with their caregivers and gain the potential to break the entire medical system. They will participate in research, gather information, and keep abreast of the latest developments. Although such an approach has many advantages, for laymen, medicine is not an easy-to-understand knowledge. During the treatment process, professional medical personnel in various fields must treat patients as partners and be ready to answer their questions. These “highly privileged patients†will apply for clinical trials.
Some even buy biotech companies for independent testing. In the absence of supervision, emotional testers will abandon ethics in garage laboratories. In general, such practices have advantages and disadvantages, so we should be prepared for new medical services. Future pharmaceutical companies will negotiate with patients to make medical decisions that best suit the patient's interests.
.jpg)
Promote pharmaceutical reform through health gamification
The incentives for patients and professional medical staff currently employed by pharmaceutical companies are outdated. They need to turn their attention to gamification to attract netizens and improve customer loyalty and pharmaceutical image. For example, Pokemon Go changed the entire game industry in a few weeks. It allows players to leave the house and keep moving, which really gives them a healthier lifestyle. Whenever people start to stay away from an advertising platform, we need to create a new advertising platform. And the new advertising platform needs to be attractive enough to customers and provide relevant information to help them make medical decisions.
Highly privileged patients will resent the term “loyalty†because it implies that the patient must obey the order. Therefore, patients will be motivated by making decisions with caregivers.
.jpg)
The cardiac marker diagnostic test measures the concentration of certain proteins, biomarkers that indicate the presence or severity of cardiovascular disease (CVD). The most common cardiovascular diseases include cardiac arrest (SCA), acute myocardial infarction (AMI), congestive heart failure (CHF), and atherosclerosis. Each year, an estimated 17 million people worldwide die from cardiovascular disease. This TriMark publication report describes specific market segments, including size, of the in vitro diagnostic (IVD) market specifically for cardiac marker testing; Economic growth; Industry trend; Product development and investment; And clinical measurement equipment, reagents and supplies. The highly intriguing growth areas of heart markers covered in this review include the cardiac rapid test market, troponin, cK-MB, and BNP tests. Heart failure, myoglobin, homocysteine (Hcy), C-reactive protein (CRP), pulmonary embolism (PE) (D -dimer test), low-density and high-density lipoprotein (LDL and HDL), stroke, cardiac enzymes, albumin, cardiac markers for clinical decision making, renal failure cardiac markers.
Cardiac Markers Tests,Ctni Test Cassette,Troponin I Test,Myo Test Cassette,cTnI/Myo/CK-MB Panel Test
Changchun ZYF science and technology CO.,LTD , https://www.zyf-medical.com